<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00767689</url>
  </required_header>
  <id_info>
    <org_study_id>08-069</org_study_id>
    <nct_id>NCT00767689</nct_id>
  </id_info>
  <brief_title>A Randomized Trial to Determine if Vitamin B6 Can Prevent Hand and Foot Syndrome in Cancer Patients Treated With Capecitabine Chemotherapy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>John H. Stroger Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>John H. Stroger Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Capecitabine (Xeloda) a drug in cancer therapy. Its use is limited often by its toxicities.
      This study is asking if vitamin B6 can prevent one of the common toxicities of xeloda which
      is numbness and/or rash of the hands and feet, a condition called Hand and Foot syndrome.
      patients , starting capecitabine chemotherapy for their cancer, will participate in this
      study at John H. Stroger Jr. Hospital of Cook County. They will be randomized to receive
      either vitamin B6 or a placebo. investigators and patients will be blinded to the
      intervention.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2008</start_date>
  <completion_date type="Anticipated">May 2010</completion_date>
  <primary_completion_date type="Anticipated">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To determine the incidence of vitamine B6 in patient receiving vitamin b6</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The severity of hand and foot syndrome in patients receiving capecitabine</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Hand and Foot Syndrome</condition>
  <arm_group>
    <arm_group_label>vitamin B6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patient receiving xeloda and vitamin B6</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>patient receiving xeloda and placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vitamin b6</intervention_name>
    <description>vitamin b6 100 mg po daily</description>
    <arm_group_label>vitamin B6</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo is given in the placebo arm</description>
    <arm_group_label>2 placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any adult patient starting capecitabine-containing chemotherapy

          -  Has never had capecitabine before

          -  Performance status 0-2 using the ECOG classification

          -  Life expectancy more than 6 months

          -  Agreed to stop any vitamin supplements, apart from vitamin D.

          -  Liver function studies including AST/ALT within 3x upper limit of normal

          -  Signed informed consent must be obtained from participating individuals
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Tareq Braik, MD</last_name>
    <phone>312-8390060</phone>
    <email>tareqbk410@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>John H stroger Jr hospital of cook county</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2008</study_first_submitted>
  <study_first_submitted_qc>October 6, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2008</study_first_posted>
  <last_update_submitted>August 3, 2009</last_update_submitted>
  <last_update_submitted_qc>August 3, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Susan McDunn</name_title>
    <organization>John H. Stroger Jr Hospital of cook county</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Hand-Foot Syndrome</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin B 6</mesh_term>
    <mesh_term>Pyridoxal</mesh_term>
    <mesh_term>Pyridoxine</mesh_term>
    <mesh_term>Vitamin B Complex</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

